nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—PLAU—breast cancer	0.552	1	CbGaD
Amiloride—SLC9A1—mammary gland—breast cancer	0.00324	0.0307	CbGeAlD
Amiloride—SCNN1B—mammary gland—breast cancer	0.00291	0.0276	CbGeAlD
Amiloride—SCNN1G—nipple—breast cancer	0.00285	0.027	CbGeAlD
Amiloride—SCNN1A—mammary gland—breast cancer	0.00269	0.0255	CbGeAlD
Amiloride—SLC9A1—nipple—breast cancer	0.00268	0.0254	CbGeAlD
Amiloride—ASIC2—endometrium—breast cancer	0.00267	0.0253	CbGeAlD
Amiloride—PLAU—nipple—breast cancer	0.00254	0.0241	CbGeAlD
Amiloride—ASIC2—pituitary gland—breast cancer	0.00242	0.0229	CbGeAlD
Amiloride—SCNN1B—nipple—breast cancer	0.00241	0.0228	CbGeAlD
Amiloride—AOC1—embryo—breast cancer	0.00231	0.0219	CbGeAlD
Amiloride—SLC9A1—embryo—breast cancer	0.00221	0.0209	CbGeAlD
Amiloride—SCNN1D—epithelium—breast cancer	0.00192	0.0182	CbGeAlD
Amiloride—SLC9A1—epithelium—breast cancer	0.0018	0.0171	CbGeAlD
Amiloride—SCNN1G—endometrium—breast cancer	0.00172	0.0163	CbGeAlD
Amiloride—SLC9A1—skin of body—breast cancer	0.00172	0.0163	CbGeAlD
Amiloride—PLAU—epithelium—breast cancer	0.00171	0.0162	CbGeAlD
Amiloride—AOC1—endometrium—breast cancer	0.00169	0.016	CbGeAlD
Amiloride—PLAU—skin of body—breast cancer	0.00163	0.0154	CbGeAlD
Amiloride—SCNN1B—epithelium—breast cancer	0.00162	0.0154	CbGeAlD
Amiloride—SCNN1G—pituitary gland—breast cancer	0.00156	0.0148	CbGeAlD
Amiloride—PLAU—endometrium—breast cancer	0.00153	0.0145	CbGeAlD
Amiloride—ASIC1—adipose tissue—breast cancer	0.00152	0.0144	CbGeAlD
Amiloride—SCNN1A—epithelium—breast cancer	0.0015	0.0142	CbGeAlD
Amiloride—SLC9A1—adipose tissue—breast cancer	0.00146	0.0138	CbGeAlD
Amiloride—SCNN1B—endometrium—breast cancer	0.00145	0.0138	CbGeAlD
Amiloride—SCNN1G—female reproductive system—breast cancer	0.00143	0.0135	CbGeAlD
Amiloride—SCNN1D—female reproductive system—breast cancer	0.00143	0.0135	CbGeAlD
Amiloride—PLAU—uterus—breast cancer	0.00141	0.0134	CbGeAlD
Amiloride—AOC1—female reproductive system—breast cancer	0.0014	0.0133	CbGeAlD
Amiloride—ASIC1—female reproductive system—breast cancer	0.0014	0.0133	CbGeAlD
Amiloride—SCNN1D—adrenal gland—breast cancer	0.00139	0.0132	CbGeAlD
Amiloride—PLAU—pituitary gland—breast cancer	0.00139	0.0132	CbGeAlD
Amiloride—PLAU—adipose tissue—breast cancer	0.00138	0.0131	CbGeAlD
Amiloride—ASIC1—adrenal gland—breast cancer	0.00137	0.0129	CbGeAlD
Amiloride—SLC9A1—female reproductive system—breast cancer	0.00134	0.0127	CbGeAlD
Amiloride—PLAU—Dexamethasone—Fluoxymesterone—breast cancer	0.00133	0.5	CbGdCrCtD
Amiloride—PLAU—Betamethasone—Fluoxymesterone—breast cancer	0.00133	0.5	CbGdCrCtD
Amiloride—AOC1—bone marrow—breast cancer	0.00132	0.0125	CbGeAlD
Amiloride—SCNN1B—adipose tissue—breast cancer	0.00131	0.0124	CbGeAlD
Amiloride—SLC9A1—adrenal gland—breast cancer	0.00131	0.0124	CbGeAlD
Amiloride—ASIC1—female gonad—breast cancer	0.00127	0.0121	CbGeAlD
Amiloride—PLAU—female reproductive system—breast cancer	0.00127	0.012	CbGeAlD
Amiloride—SLC9A1—bone marrow—breast cancer	0.00127	0.012	CbGeAlD
Amiloride—PLAU—adrenal gland—breast cancer	0.00124	0.0117	CbGeAlD
Amiloride—SCNN1A—uterus—breast cancer	0.00124	0.0117	CbGeAlD
Amiloride—SLC9A1—female gonad—breast cancer	0.00122	0.0116	CbGeAlD
Amiloride—SCNN1A—pituitary gland—breast cancer	0.00122	0.0115	CbGeAlD
Amiloride—SCNN1A—adipose tissue—breast cancer	0.00121	0.0115	CbGeAlD
Amiloride—SCNN1D—endocrine gland—breast cancer	0.00121	0.0114	CbGeAlD
Amiloride—SCNN1B—female reproductive system—breast cancer	0.0012	0.0114	CbGeAlD
Amiloride—PLAU—bone marrow—breast cancer	0.0012	0.0114	CbGeAlD
Amiloride—ASIC1—endocrine gland—breast cancer	0.00118	0.0112	CbGeAlD
Amiloride—AOC1—endocrine gland—breast cancer	0.00118	0.0112	CbGeAlD
Amiloride—SCNN1B—adrenal gland—breast cancer	0.00118	0.0111	CbGeAlD
Amiloride—PLAU—female gonad—breast cancer	0.00116	0.011	CbGeAlD
Amiloride—SLC9A1—endocrine gland—breast cancer	0.00113	0.0107	CbGeAlD
Amiloride—SCNN1A—female reproductive system—breast cancer	0.00111	0.0105	CbGeAlD
Amiloride—SCNN1A—adrenal gland—breast cancer	0.00109	0.0103	CbGeAlD
Amiloride—SLC22A4—mammary gland—breast cancer	0.00108	0.0102	CbGeAlD
Amiloride—PLAU—endocrine gland—breast cancer	0.00108	0.0102	CbGeAlD
Amiloride—SCNN1B—endocrine gland—breast cancer	0.00102	0.00966	CbGeAlD
Amiloride—SCNN1A—female gonad—breast cancer	0.00101	0.00959	CbGeAlD
Amiloride—SCNN1A—endocrine gland—breast cancer	0.000942	0.00892	CbGeAlD
Amiloride—SCNN1D—lymph node—breast cancer	0.000834	0.0079	CbGeAlD
Amiloride—ASIC1—lymph node—breast cancer	0.000819	0.00776	CbGeAlD
Amiloride—AOC1—lymph node—breast cancer	0.000819	0.00776	CbGeAlD
Amiloride—SLC9A1—lymph node—breast cancer	0.000784	0.00743	CbGeAlD
Amiloride—PLAU—lymph node—breast cancer	0.000744	0.00704	CbGeAlD
Amiloride—SCNN1B—lymph node—breast cancer	0.000705	0.00668	CbGeAlD
Amiloride—SCNN1A—lymph node—breast cancer	0.000651	0.00617	CbGeAlD
Amiloride—SLC22A4—endometrium—breast cancer	0.000538	0.0051	CbGeAlD
Amiloride—SLC22A4—pituitary gland—breast cancer	0.000487	0.00461	CbGeAlD
Amiloride—SLC22A4—adipose tissue—breast cancer	0.000485	0.0046	CbGeAlD
Amiloride—SLC22A1—adipose tissue—breast cancer	0.000462	0.00438	CbGeAlD
Amiloride—SLC22A4—female reproductive system—breast cancer	0.000446	0.00422	CbGeAlD
Amiloride—SLC22A4—adrenal gland—breast cancer	0.000435	0.00412	CbGeAlD
Amiloride—SLC22A4—bone marrow—breast cancer	0.000421	0.00399	CbGeAlD
Amiloride—SLC22A1—endocrine gland—breast cancer	0.000359	0.0034	CbGeAlD
Amiloride—SLC22A4—lymph node—breast cancer	0.000261	0.00247	CbGeAlD
Amiloride—Dizziness—Thiotepa—breast cancer	8.32e-05	0.000475	CcSEcCtD
Amiloride—Rash—Vinorelbine—breast cancer	8.31e-05	0.000474	CcSEcCtD
Amiloride—Dermatitis—Vinorelbine—breast cancer	8.3e-05	0.000474	CcSEcCtD
Amiloride—Abdominal distension—Doxorubicin—breast cancer	8.3e-05	0.000474	CcSEcCtD
Amiloride—Headache—Vinorelbine—breast cancer	8.25e-05	0.000471	CcSEcCtD
Amiloride—Pollakiuria—Epirubicin—breast cancer	8.23e-05	0.00047	CcSEcCtD
Amiloride—Palpitations—Docetaxel—breast cancer	8.13e-05	0.000464	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Paclitaxel—breast cancer	8.07e-05	0.000461	CcSEcCtD
Amiloride—Cough—Docetaxel—breast cancer	8.03e-05	0.000458	CcSEcCtD
Amiloride—Angina pectoris—Doxorubicin—breast cancer	8.03e-05	0.000458	CcSEcCtD
Amiloride—Insomnia—Paclitaxel—breast cancer	8.01e-05	0.000457	CcSEcCtD
Amiloride—Vertigo—Capecitabine—breast cancer	8e-05	0.000457	CcSEcCtD
Amiloride—Vomiting—Thiotepa—breast cancer	8e-05	0.000457	CcSEcCtD
Amiloride—Paraesthesia—Paclitaxel—breast cancer	7.96e-05	0.000454	CcSEcCtD
Amiloride—Rash—Thiotepa—breast cancer	7.93e-05	0.000453	CcSEcCtD
Amiloride—Dermatitis—Thiotepa—breast cancer	7.92e-05	0.000452	CcSEcCtD
Amiloride—Dyspnoea—Paclitaxel—breast cancer	7.9e-05	0.000451	CcSEcCtD
Amiloride—Headache—Thiotepa—breast cancer	7.88e-05	0.00045	CcSEcCtD
Amiloride—Somnolence—Paclitaxel—breast cancer	7.88e-05	0.00045	CcSEcCtD
Amiloride—Palpitations—Capecitabine—breast cancer	7.87e-05	0.000449	CcSEcCtD
Amiloride—Arthralgia—Docetaxel—breast cancer	7.83e-05	0.000447	CcSEcCtD
Amiloride—Chest pain—Docetaxel—breast cancer	7.83e-05	0.000447	CcSEcCtD
Amiloride—Nausea—Vinorelbine—breast cancer	7.82e-05	0.000447	CcSEcCtD
Amiloride—Dyspepsia—Paclitaxel—breast cancer	7.8e-05	0.000445	CcSEcCtD
Amiloride—Asthenia—Mitoxantrone—breast cancer	7.79e-05	0.000445	CcSEcCtD
Amiloride—Asthenia—Irinotecan—breast cancer	7.79e-05	0.000445	CcSEcCtD
Amiloride—Cough—Capecitabine—breast cancer	7.77e-05	0.000444	CcSEcCtD
Amiloride—Jaundice—Epirubicin—breast cancer	7.74e-05	0.000442	CcSEcCtD
Amiloride—Dysuria—Doxorubicin—breast cancer	7.71e-05	0.00044	CcSEcCtD
Amiloride—Neutropenia—Doxorubicin—breast cancer	7.71e-05	0.00044	CcSEcCtD
Amiloride—Decreased appetite—Paclitaxel—breast cancer	7.7e-05	0.00044	CcSEcCtD
Amiloride—Haemoglobin—Methotrexate—breast cancer	7.66e-05	0.000437	CcSEcCtD
Amiloride—Gastrointestinal disorder—Paclitaxel—breast cancer	7.65e-05	0.000437	CcSEcCtD
Amiloride—Fatigue—Paclitaxel—breast cancer	7.64e-05	0.000436	CcSEcCtD
Amiloride—Haemorrhage—Methotrexate—breast cancer	7.62e-05	0.000435	CcSEcCtD
Amiloride—Pollakiuria—Doxorubicin—breast cancer	7.61e-05	0.000435	CcSEcCtD
Amiloride—Asthenia—Gemcitabine—breast cancer	7.59e-05	0.000433	CcSEcCtD
Amiloride—Arthralgia—Capecitabine—breast cancer	7.58e-05	0.000433	CcSEcCtD
Amiloride—Chest pain—Capecitabine—breast cancer	7.58e-05	0.000433	CcSEcCtD
Amiloride—Pain—Paclitaxel—breast cancer	7.58e-05	0.000432	CcSEcCtD
Amiloride—Constipation—Paclitaxel—breast cancer	7.58e-05	0.000432	CcSEcCtD
Amiloride—Confusional state—Docetaxel—breast cancer	7.57e-05	0.000432	CcSEcCtD
Amiloride—Pruritus—Gemcitabine—breast cancer	7.49e-05	0.000427	CcSEcCtD
Amiloride—Nausea—Thiotepa—breast cancer	7.47e-05	0.000426	CcSEcCtD
Amiloride—Diarrhoea—Mitoxantrone—breast cancer	7.43e-05	0.000424	CcSEcCtD
Amiloride—Diarrhoea—Irinotecan—breast cancer	7.43e-05	0.000424	CcSEcCtD
Amiloride—Shock—Docetaxel—breast cancer	7.39e-05	0.000422	CcSEcCtD
Amiloride—Pruritus—Fluorouracil—breast cancer	7.36e-05	0.00042	CcSEcCtD
Amiloride—Visual impairment—Methotrexate—breast cancer	7.34e-05	0.000419	CcSEcCtD
Amiloride—Confusional state—Capecitabine—breast cancer	7.33e-05	0.000418	CcSEcCtD
Amiloride—Feeling abnormal—Paclitaxel—breast cancer	7.3e-05	0.000417	CcSEcCtD
Amiloride—Bradycardia—Epirubicin—breast cancer	7.26e-05	0.000414	CcSEcCtD
Amiloride—Gastrointestinal pain—Paclitaxel—breast cancer	7.24e-05	0.000414	CcSEcCtD
Amiloride—Diarrhoea—Gemcitabine—breast cancer	7.24e-05	0.000413	CcSEcCtD
Amiloride—Dizziness—Irinotecan—breast cancer	7.18e-05	0.00041	CcSEcCtD
Amiloride—Haemoglobin—Epirubicin—breast cancer	7.17e-05	0.000409	CcSEcCtD
Amiloride—Jaundice—Doxorubicin—breast cancer	7.16e-05	0.000409	CcSEcCtD
Amiloride—Anorexia—Docetaxel—breast cancer	7.16e-05	0.000409	CcSEcCtD
Amiloride—Shock—Capecitabine—breast cancer	7.15e-05	0.000408	CcSEcCtD
Amiloride—Haemorrhage—Epirubicin—breast cancer	7.13e-05	0.000407	CcSEcCtD
Amiloride—Diarrhoea—Fluorouracil—breast cancer	7.12e-05	0.000406	CcSEcCtD
Amiloride—Tinnitus—Methotrexate—breast cancer	7.1e-05	0.000405	CcSEcCtD
Amiloride—Abdominal pain—Paclitaxel—breast cancer	7e-05	0.0004	CcSEcCtD
Amiloride—Anorexia—Capecitabine—breast cancer	6.93e-05	0.000396	CcSEcCtD
Amiloride—Vomiting—Mitoxantrone—breast cancer	6.91e-05	0.000394	CcSEcCtD
Amiloride—Vomiting—Irinotecan—breast cancer	6.91e-05	0.000394	CcSEcCtD
Amiloride—Dizziness—Fluorouracil—breast cancer	6.88e-05	0.000393	CcSEcCtD
Amiloride—Visual impairment—Epirubicin—breast cancer	6.87e-05	0.000392	CcSEcCtD
Amiloride—Rash—Irinotecan—breast cancer	6.85e-05	0.000391	CcSEcCtD
Amiloride—Rash—Mitoxantrone—breast cancer	6.85e-05	0.000391	CcSEcCtD
Amiloride—Dermatitis—Mitoxantrone—breast cancer	6.84e-05	0.000391	CcSEcCtD
Amiloride—Dermatitis—Irinotecan—breast cancer	6.84e-05	0.000391	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Docetaxel—breast cancer	6.84e-05	0.000391	CcSEcCtD
Amiloride—Headache—Irinotecan—breast cancer	6.81e-05	0.000388	CcSEcCtD
Amiloride—Headache—Mitoxantrone—breast cancer	6.81e-05	0.000388	CcSEcCtD
Amiloride—Insomnia—Docetaxel—breast cancer	6.79e-05	0.000388	CcSEcCtD
Amiloride—Paraesthesia—Docetaxel—breast cancer	6.74e-05	0.000385	CcSEcCtD
Amiloride—Alopecia—Methotrexate—breast cancer	6.73e-05	0.000384	CcSEcCtD
Amiloride—Vomiting—Gemcitabine—breast cancer	6.73e-05	0.000384	CcSEcCtD
Amiloride—Bradycardia—Doxorubicin—breast cancer	6.72e-05	0.000383	CcSEcCtD
Amiloride—Dyspnoea—Docetaxel—breast cancer	6.69e-05	0.000382	CcSEcCtD
Amiloride—Somnolence—Docetaxel—breast cancer	6.68e-05	0.000381	CcSEcCtD
Amiloride—Rash—Gemcitabine—breast cancer	6.67e-05	0.000381	CcSEcCtD
Amiloride—Dermatitis—Gemcitabine—breast cancer	6.67e-05	0.00038	CcSEcCtD
Amiloride—Tinnitus—Epirubicin—breast cancer	6.65e-05	0.000379	CcSEcCtD
Amiloride—Haemoglobin—Doxorubicin—breast cancer	6.63e-05	0.000378	CcSEcCtD
Amiloride—Headache—Gemcitabine—breast cancer	6.63e-05	0.000378	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Capecitabine—breast cancer	6.62e-05	0.000378	CcSEcCtD
Amiloride—Vomiting—Fluorouracil—breast cancer	6.62e-05	0.000378	CcSEcCtD
Amiloride—Dyspepsia—Docetaxel—breast cancer	6.61e-05	0.000377	CcSEcCtD
Amiloride—Haemorrhage—Doxorubicin—breast cancer	6.6e-05	0.000377	CcSEcCtD
Amiloride—Insomnia—Capecitabine—breast cancer	6.58e-05	0.000375	CcSEcCtD
Amiloride—Rash—Fluorouracil—breast cancer	6.56e-05	0.000374	CcSEcCtD
Amiloride—Dermatitis—Fluorouracil—breast cancer	6.55e-05	0.000374	CcSEcCtD
Amiloride—Paraesthesia—Capecitabine—breast cancer	6.53e-05	0.000373	CcSEcCtD
Amiloride—Decreased appetite—Docetaxel—breast cancer	6.53e-05	0.000373	CcSEcCtD
Amiloride—Headache—Fluorouracil—breast cancer	6.52e-05	0.000372	CcSEcCtD
Amiloride—Gastrointestinal disorder—Docetaxel—breast cancer	6.48e-05	0.00037	CcSEcCtD
Amiloride—Dyspnoea—Capecitabine—breast cancer	6.48e-05	0.00037	CcSEcCtD
Amiloride—Fatigue—Docetaxel—breast cancer	6.47e-05	0.00037	CcSEcCtD
Amiloride—Nausea—Irinotecan—breast cancer	6.45e-05	0.000368	CcSEcCtD
Amiloride—Nausea—Mitoxantrone—breast cancer	6.45e-05	0.000368	CcSEcCtD
Amiloride—Pain—Docetaxel—breast cancer	6.42e-05	0.000367	CcSEcCtD
Amiloride—Constipation—Docetaxel—breast cancer	6.42e-05	0.000367	CcSEcCtD
Amiloride—Back pain—Methotrexate—breast cancer	6.41e-05	0.000366	CcSEcCtD
Amiloride—Dyspepsia—Capecitabine—breast cancer	6.4e-05	0.000365	CcSEcCtD
Amiloride—Visual impairment—Doxorubicin—breast cancer	6.36e-05	0.000363	CcSEcCtD
Amiloride—Asthenia—Paclitaxel—breast cancer	6.36e-05	0.000363	CcSEcCtD
Amiloride—Decreased appetite—Capecitabine—breast cancer	6.32e-05	0.000361	CcSEcCtD
Amiloride—Alopecia—Epirubicin—breast cancer	6.3e-05	0.00036	CcSEcCtD
Amiloride—Nausea—Gemcitabine—breast cancer	6.29e-05	0.000359	CcSEcCtD
Amiloride—Gastrointestinal disorder—Capecitabine—breast cancer	6.28e-05	0.000358	CcSEcCtD
Amiloride—Fatigue—Capecitabine—breast cancer	6.27e-05	0.000358	CcSEcCtD
Amiloride—Pruritus—Paclitaxel—breast cancer	6.27e-05	0.000358	CcSEcCtD
Amiloride—Constipation—Capecitabine—breast cancer	6.22e-05	0.000355	CcSEcCtD
Amiloride—Pain—Capecitabine—breast cancer	6.22e-05	0.000355	CcSEcCtD
Amiloride—Feeling abnormal—Docetaxel—breast cancer	6.19e-05	0.000353	CcSEcCtD
Amiloride—Nausea—Fluorouracil—breast cancer	6.18e-05	0.000353	CcSEcCtD
Amiloride—Tinnitus—Doxorubicin—breast cancer	6.15e-05	0.000351	CcSEcCtD
Amiloride—Gastrointestinal pain—Docetaxel—breast cancer	6.14e-05	0.00035	CcSEcCtD
Amiloride—Flatulence—Epirubicin—breast cancer	6.12e-05	0.000349	CcSEcCtD
Amiloride—Tension—Epirubicin—breast cancer	6.09e-05	0.000348	CcSEcCtD
Amiloride—Diarrhoea—Paclitaxel—breast cancer	6.06e-05	0.000346	CcSEcCtD
Amiloride—Nervousness—Epirubicin—breast cancer	6.03e-05	0.000344	CcSEcCtD
Amiloride—Back pain—Epirubicin—breast cancer	6e-05	0.000343	CcSEcCtD
Amiloride—Feeling abnormal—Capecitabine—breast cancer	5.99e-05	0.000342	CcSEcCtD
Amiloride—Muscle spasms—Epirubicin—breast cancer	5.97e-05	0.000341	CcSEcCtD
Amiloride—Vertigo—Methotrexate—breast cancer	5.96e-05	0.00034	CcSEcCtD
Amiloride—Gastrointestinal pain—Capecitabine—breast cancer	5.95e-05	0.000339	CcSEcCtD
Amiloride—Abdominal pain—Docetaxel—breast cancer	5.94e-05	0.000339	CcSEcCtD
Amiloride—Dizziness—Paclitaxel—breast cancer	5.86e-05	0.000334	CcSEcCtD
Amiloride—Alopecia—Doxorubicin—breast cancer	5.83e-05	0.000333	CcSEcCtD
Amiloride—Cough—Methotrexate—breast cancer	5.79e-05	0.00033	CcSEcCtD
Amiloride—Abdominal pain—Capecitabine—breast cancer	5.75e-05	0.000328	CcSEcCtD
Amiloride—Flatulence—Doxorubicin—breast cancer	5.66e-05	0.000323	CcSEcCtD
Amiloride—Arthralgia—Methotrexate—breast cancer	5.65e-05	0.000322	CcSEcCtD
Amiloride—Chest pain—Methotrexate—breast cancer	5.65e-05	0.000322	CcSEcCtD
Amiloride—Tension—Doxorubicin—breast cancer	5.64e-05	0.000322	CcSEcCtD
Amiloride—Vomiting—Paclitaxel—breast cancer	5.63e-05	0.000322	CcSEcCtD
Amiloride—Rash—Paclitaxel—breast cancer	5.59e-05	0.000319	CcSEcCtD
Amiloride—Dermatitis—Paclitaxel—breast cancer	5.58e-05	0.000319	CcSEcCtD
Amiloride—Nervousness—Doxorubicin—breast cancer	5.58e-05	0.000318	CcSEcCtD
Amiloride—Vertigo—Epirubicin—breast cancer	5.58e-05	0.000318	CcSEcCtD
Amiloride—Back pain—Doxorubicin—breast cancer	5.55e-05	0.000317	CcSEcCtD
Amiloride—Headache—Paclitaxel—breast cancer	5.55e-05	0.000317	CcSEcCtD
Amiloride—Muscle spasms—Doxorubicin—breast cancer	5.52e-05	0.000315	CcSEcCtD
Amiloride—Palpitations—Epirubicin—breast cancer	5.48e-05	0.000313	CcSEcCtD
Amiloride—Confusional state—Methotrexate—breast cancer	5.46e-05	0.000311	CcSEcCtD
Amiloride—Cough—Epirubicin—breast cancer	5.42e-05	0.000309	CcSEcCtD
Amiloride—Asthenia—Docetaxel—breast cancer	5.39e-05	0.000308	CcSEcCtD
Amiloride—Pruritus—Docetaxel—breast cancer	5.31e-05	0.000303	CcSEcCtD
Amiloride—Chest pain—Epirubicin—breast cancer	5.28e-05	0.000302	CcSEcCtD
Amiloride—Arthralgia—Epirubicin—breast cancer	5.28e-05	0.000302	CcSEcCtD
Amiloride—Nausea—Paclitaxel—breast cancer	5.26e-05	0.0003	CcSEcCtD
Amiloride—Asthenia—Capecitabine—breast cancer	5.22e-05	0.000298	CcSEcCtD
Amiloride—Vertigo—Doxorubicin—breast cancer	5.16e-05	0.000294	CcSEcCtD
Amiloride—Anorexia—Methotrexate—breast cancer	5.16e-05	0.000294	CcSEcCtD
Amiloride—Pruritus—Capecitabine—breast cancer	5.14e-05	0.000294	CcSEcCtD
Amiloride—Diarrhoea—Docetaxel—breast cancer	5.14e-05	0.000293	CcSEcCtD
Amiloride—Confusional state—Epirubicin—breast cancer	5.11e-05	0.000292	CcSEcCtD
Amiloride—Palpitations—Doxorubicin—breast cancer	5.07e-05	0.00029	CcSEcCtD
Amiloride—Cough—Doxorubicin—breast cancer	5.01e-05	0.000286	CcSEcCtD
Amiloride—Shock—Epirubicin—breast cancer	4.98e-05	0.000284	CcSEcCtD
Amiloride—Diarrhoea—Capecitabine—breast cancer	4.97e-05	0.000284	CcSEcCtD
Amiloride—Dizziness—Docetaxel—breast cancer	4.97e-05	0.000283	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Methotrexate—breast cancer	4.93e-05	0.000281	CcSEcCtD
Amiloride—Insomnia—Methotrexate—breast cancer	4.9e-05	0.000279	CcSEcCtD
Amiloride—Arthralgia—Doxorubicin—breast cancer	4.89e-05	0.000279	CcSEcCtD
Amiloride—Chest pain—Doxorubicin—breast cancer	4.89e-05	0.000279	CcSEcCtD
Amiloride—Paraesthesia—Methotrexate—breast cancer	4.86e-05	0.000277	CcSEcCtD
Amiloride—Anorexia—Epirubicin—breast cancer	4.83e-05	0.000276	CcSEcCtD
Amiloride—Dyspnoea—Methotrexate—breast cancer	4.83e-05	0.000275	CcSEcCtD
Amiloride—Somnolence—Methotrexate—breast cancer	4.81e-05	0.000275	CcSEcCtD
Amiloride—Dizziness—Capecitabine—breast cancer	4.81e-05	0.000274	CcSEcCtD
Amiloride—Vomiting—Docetaxel—breast cancer	4.77e-05	0.000273	CcSEcCtD
Amiloride—Dyspepsia—Methotrexate—breast cancer	4.76e-05	0.000272	CcSEcCtD
Amiloride—Rash—Docetaxel—breast cancer	4.73e-05	0.00027	CcSEcCtD
Amiloride—Dermatitis—Docetaxel—breast cancer	4.73e-05	0.00027	CcSEcCtD
Amiloride—Confusional state—Doxorubicin—breast cancer	4.73e-05	0.00027	CcSEcCtD
Amiloride—Decreased appetite—Methotrexate—breast cancer	4.7e-05	0.000269	CcSEcCtD
Amiloride—Headache—Docetaxel—breast cancer	4.7e-05	0.000269	CcSEcCtD
Amiloride—Gastrointestinal disorder—Methotrexate—breast cancer	4.67e-05	0.000267	CcSEcCtD
Amiloride—Fatigue—Methotrexate—breast cancer	4.67e-05	0.000266	CcSEcCtD
Amiloride—Pain—Methotrexate—breast cancer	4.63e-05	0.000264	CcSEcCtD
Amiloride—Vomiting—Capecitabine—breast cancer	4.62e-05	0.000264	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Epirubicin—breast cancer	4.61e-05	0.000263	CcSEcCtD
Amiloride—Shock—Doxorubicin—breast cancer	4.61e-05	0.000263	CcSEcCtD
Amiloride—Rash—Capecitabine—breast cancer	4.58e-05	0.000262	CcSEcCtD
Amiloride—Insomnia—Epirubicin—breast cancer	4.58e-05	0.000261	CcSEcCtD
Amiloride—Dermatitis—Capecitabine—breast cancer	4.58e-05	0.000261	CcSEcCtD
Amiloride—Headache—Capecitabine—breast cancer	4.55e-05	0.00026	CcSEcCtD
Amiloride—Paraesthesia—Epirubicin—breast cancer	4.55e-05	0.00026	CcSEcCtD
Amiloride—Dyspnoea—Epirubicin—breast cancer	4.52e-05	0.000258	CcSEcCtD
Amiloride—Somnolence—Epirubicin—breast cancer	4.5e-05	0.000257	CcSEcCtD
Amiloride—Anorexia—Doxorubicin—breast cancer	4.47e-05	0.000255	CcSEcCtD
Amiloride—Nausea—Docetaxel—breast cancer	4.46e-05	0.000255	CcSEcCtD
Amiloride—Feeling abnormal—Methotrexate—breast cancer	4.46e-05	0.000255	CcSEcCtD
Amiloride—Dyspepsia—Epirubicin—breast cancer	4.46e-05	0.000254	CcSEcCtD
Amiloride—Gastrointestinal pain—Methotrexate—breast cancer	4.43e-05	0.000253	CcSEcCtD
Amiloride—Decreased appetite—Epirubicin—breast cancer	4.4e-05	0.000251	CcSEcCtD
Amiloride—Gastrointestinal disorder—Epirubicin—breast cancer	4.37e-05	0.00025	CcSEcCtD
Amiloride—Fatigue—Epirubicin—breast cancer	4.37e-05	0.000249	CcSEcCtD
Amiloride—Pain—Epirubicin—breast cancer	4.33e-05	0.000247	CcSEcCtD
Amiloride—Constipation—Epirubicin—breast cancer	4.33e-05	0.000247	CcSEcCtD
Amiloride—Nausea—Capecitabine—breast cancer	4.32e-05	0.000246	CcSEcCtD
Amiloride—Abdominal pain—Methotrexate—breast cancer	4.28e-05	0.000244	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Doxorubicin—breast cancer	4.27e-05	0.000244	CcSEcCtD
Amiloride—Insomnia—Doxorubicin—breast cancer	4.24e-05	0.000242	CcSEcCtD
Amiloride—Paraesthesia—Doxorubicin—breast cancer	4.21e-05	0.00024	CcSEcCtD
Amiloride—Dyspnoea—Doxorubicin—breast cancer	4.18e-05	0.000238	CcSEcCtD
Amiloride—Feeling abnormal—Epirubicin—breast cancer	4.17e-05	0.000238	CcSEcCtD
Amiloride—Somnolence—Doxorubicin—breast cancer	4.17e-05	0.000238	CcSEcCtD
Amiloride—Gastrointestinal pain—Epirubicin—breast cancer	4.14e-05	0.000236	CcSEcCtD
Amiloride—Dyspepsia—Doxorubicin—breast cancer	4.13e-05	0.000235	CcSEcCtD
Amiloride—Decreased appetite—Doxorubicin—breast cancer	4.07e-05	0.000233	CcSEcCtD
Amiloride—Gastrointestinal disorder—Doxorubicin—breast cancer	4.05e-05	0.000231	CcSEcCtD
Amiloride—Fatigue—Doxorubicin—breast cancer	4.04e-05	0.000231	CcSEcCtD
Amiloride—Pain—Doxorubicin—breast cancer	4.01e-05	0.000229	CcSEcCtD
Amiloride—Constipation—Doxorubicin—breast cancer	4.01e-05	0.000229	CcSEcCtD
Amiloride—Abdominal pain—Epirubicin—breast cancer	4e-05	0.000229	CcSEcCtD
Amiloride—Asthenia—Methotrexate—breast cancer	3.88e-05	0.000222	CcSEcCtD
Amiloride—Feeling abnormal—Doxorubicin—breast cancer	3.86e-05	0.00022	CcSEcCtD
Amiloride—Gastrointestinal pain—Doxorubicin—breast cancer	3.83e-05	0.000219	CcSEcCtD
Amiloride—Pruritus—Methotrexate—breast cancer	3.83e-05	0.000219	CcSEcCtD
Amiloride—Abdominal pain—Doxorubicin—breast cancer	3.7e-05	0.000211	CcSEcCtD
Amiloride—Diarrhoea—Methotrexate—breast cancer	3.7e-05	0.000211	CcSEcCtD
Amiloride—Asthenia—Epirubicin—breast cancer	3.63e-05	0.000207	CcSEcCtD
Amiloride—Pruritus—Epirubicin—breast cancer	3.58e-05	0.000205	CcSEcCtD
Amiloride—Dizziness—Methotrexate—breast cancer	3.58e-05	0.000204	CcSEcCtD
Amiloride—Diarrhoea—Epirubicin—breast cancer	3.47e-05	0.000198	CcSEcCtD
Amiloride—Vomiting—Methotrexate—breast cancer	3.44e-05	0.000196	CcSEcCtD
Amiloride—Rash—Methotrexate—breast cancer	3.41e-05	0.000195	CcSEcCtD
Amiloride—Dermatitis—Methotrexate—breast cancer	3.41e-05	0.000195	CcSEcCtD
Amiloride—Headache—Methotrexate—breast cancer	3.39e-05	0.000194	CcSEcCtD
Amiloride—Asthenia—Doxorubicin—breast cancer	3.36e-05	0.000192	CcSEcCtD
Amiloride—Dizziness—Epirubicin—breast cancer	3.35e-05	0.000191	CcSEcCtD
Amiloride—Pruritus—Doxorubicin—breast cancer	3.32e-05	0.000189	CcSEcCtD
Amiloride—Vomiting—Epirubicin—breast cancer	3.22e-05	0.000184	CcSEcCtD
Amiloride—Nausea—Methotrexate—breast cancer	3.21e-05	0.000184	CcSEcCtD
Amiloride—Diarrhoea—Doxorubicin—breast cancer	3.21e-05	0.000183	CcSEcCtD
Amiloride—Rash—Epirubicin—breast cancer	3.19e-05	0.000182	CcSEcCtD
Amiloride—Dermatitis—Epirubicin—breast cancer	3.19e-05	0.000182	CcSEcCtD
Amiloride—Headache—Epirubicin—breast cancer	3.17e-05	0.000181	CcSEcCtD
Amiloride—Dizziness—Doxorubicin—breast cancer	3.1e-05	0.000177	CcSEcCtD
Amiloride—Nausea—Epirubicin—breast cancer	3.01e-05	0.000172	CcSEcCtD
Amiloride—Vomiting—Doxorubicin—breast cancer	2.98e-05	0.00017	CcSEcCtD
Amiloride—Rash—Doxorubicin—breast cancer	2.95e-05	0.000169	CcSEcCtD
Amiloride—Dermatitis—Doxorubicin—breast cancer	2.95e-05	0.000169	CcSEcCtD
Amiloride—Headache—Doxorubicin—breast cancer	2.94e-05	0.000168	CcSEcCtD
Amiloride—Nausea—Doxorubicin—breast cancer	2.78e-05	0.000159	CcSEcCtD
Amiloride—SLC22A1—Metabolism—CHST9—breast cancer	1.48e-05	9.01e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—BRAF—breast cancer	1.48e-05	8.97e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CD—breast cancer	1.47e-05	8.93e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC2A2—breast cancer	1.47e-05	8.92e-05	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PIK3CA—breast cancer	1.46e-05	8.84e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SERPINE1—breast cancer	1.46e-05	8.83e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ABCG2—breast cancer	1.44e-05	8.74e-05	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TP53—breast cancer	1.41e-05	8.55e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—COX11—breast cancer	1.41e-05	8.54e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CG—breast cancer	1.4e-05	8.5e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NOS3—breast cancer	1.39e-05	8.43e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SHMT1—breast cancer	1.38e-05	8.38e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CDA—breast cancer	1.38e-05	8.38e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—BRAF—breast cancer	1.38e-05	8.36e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC2A2—breast cancer	1.37e-05	8.31e-05	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—HRAS—breast cancer	1.35e-05	8.18e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ABCG2—breast cancer	1.34e-05	8.14e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC2A5—breast cancer	1.33e-05	8.07e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLCO1B1—breast cancer	1.33e-05	8.07e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MDM2—breast cancer	1.32e-05	8e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—RAF1—breast cancer	1.31e-05	7.97e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ERBB2—breast cancer	1.3e-05	7.89e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SHMT1—breast cancer	1.29e-05	7.81e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CDA—breast cancer	1.29e-05	7.81e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APRT—breast cancer	1.28e-05	7.79e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—TFRC—breast cancer	1.28e-05	7.79e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CB—breast cancer	1.28e-05	7.78e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MTOR—breast cancer	1.28e-05	7.78e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CD4—breast cancer	1.28e-05	7.77e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTGS2—breast cancer	1.27e-05	7.71e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC2A5—breast cancer	1.24e-05	7.52e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLCO1B1—breast cancer	1.24e-05	7.52e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—MDM2—breast cancer	1.24e-05	7.51e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—NCOA2—breast cancer	1.24e-05	7.5e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—RAF1—breast cancer	1.23e-05	7.49e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CD—breast cancer	1.23e-05	7.48e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ALB—breast cancer	1.22e-05	7.38e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ANGPTL4—breast cancer	1.21e-05	7.32e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ESRRA—breast cancer	1.21e-05	7.32e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CDKN1B—breast cancer	1.2e-05	7.3e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APRT—breast cancer	1.2e-05	7.26e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—TFRC—breast cancer	1.2e-05	7.26e-05	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—AKT1—breast cancer	1.19e-05	7.22e-05	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ALB—breast cancer	1.19e-05	7.21e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC5A5—breast cancer	1.18e-05	7.15e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—NOS3—breast cancer	1.16e-05	7.06e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—MDM2—breast cancer	1.15e-05	7e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—NCOA2—breast cancer	1.15e-05	6.99e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—RAF1—breast cancer	1.15e-05	6.98e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GPI—breast cancer	1.14e-05	6.94e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HADHB—breast cancer	1.14e-05	6.94e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC2A1—breast cancer	1.14e-05	6.91e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CTNNB1—breast cancer	1.14e-05	6.9e-05	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—BRAF—breast cancer	1.13e-05	6.87e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ESRRA—breast cancer	1.13e-05	6.83e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ANGPTL4—breast cancer	1.13e-05	6.83e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CDKN1A—breast cancer	1.11e-05	6.74e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTEN—breast cancer	1.11e-05	6.72e-05	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—ALB—breast cancer	1.11e-05	6.71e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	1.1e-05	6.66e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALDH1A1—breast cancer	1.09e-05	6.62e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALDH7A1—breast cancer	1.09e-05	6.62e-05	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—RAF1—breast cancer	1.08e-05	6.52e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CB—breast cancer	1.07e-05	6.52e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GPI—breast cancer	1.07e-05	6.47e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HADHB—breast cancer	1.07e-05	6.47e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTGS2—breast cancer	1.06e-05	6.46e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	1.06e-05	6.44e-05	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—BRAF—breast cancer	1.06e-05	6.4e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—UMPS—breast cancer	1.05e-05	6.35e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PHGDH—breast cancer	1.05e-05	6.35e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ADSL—breast cancer	1.05e-05	6.35e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—FHL2—breast cancer	1.05e-05	6.35e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NME1—breast cancer	1.05e-05	6.35e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—NCOA1—breast cancer	1.04e-05	6.32e-05	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—ALB—breast cancer	1.03e-05	6.26e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SRC—breast cancer	1.03e-05	6.24e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—BRIP1—breast cancer	1.03e-05	6.23e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—LDHB—breast cancer	1.03e-05	6.23e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HPSE—breast cancer	1.03e-05	6.23e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALDH7A1—breast cancer	1.02e-05	6.17e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALDH1A1—breast cancer	1.02e-05	6.17e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—PLG—breast cancer	1.01e-05	6.16e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—STAT3—breast cancer	9.91e-06	6.01e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NME1—breast cancer	9.76e-06	5.92e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—UMPS—breast cancer	9.76e-06	5.92e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ADSL—breast cancer	9.76e-06	5.92e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—FHL2—breast cancer	9.76e-06	5.92e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PHGDH—breast cancer	9.76e-06	5.92e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTA3—breast cancer	9.73e-06	5.9e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HMMR—breast cancer	9.73e-06	5.9e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ABCC1—breast cancer	9.73e-06	5.9e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—NCOA1—breast cancer	9.7e-06	5.89e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—BRIP1—breast cancer	9.57e-06	5.8e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HPSE—breast cancer	9.57e-06	5.8e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—LDHB—breast cancer	9.57e-06	5.8e-05	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—MDM2—breast cancer	9.49e-06	5.76e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MAPK3—breast cancer	9.47e-06	5.75e-05	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—RAF1—breast cancer	9.46e-06	5.74e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—PLG—breast cancer	9.46e-06	5.74e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPARGC1B—breast cancer	9.42e-06	5.72e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—HMOX1—breast cancer	9.36e-06	5.68e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTEN—breast cancer	9.28e-06	5.63e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MYC—breast cancer	9.21e-06	5.59e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TGFB1—breast cancer	9.19e-06	5.57e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTA3—breast cancer	9.07e-06	5.5e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ABCC1—breast cancer	9.07e-06	5.5e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HMMR—breast cancer	9.07e-06	5.5e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—EGFR—breast cancer	9.01e-06	5.47e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ABCB1—breast cancer	8.99e-06	5.45e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CA9—breast cancer	8.9e-06	5.4e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTA4—breast cancer	8.9e-06	5.4e-05	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—MDM2—breast cancer	8.85e-06	5.37e-05	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—RAF1—breast cancer	8.82e-06	5.35e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPARGC1B—breast cancer	8.78e-06	5.33e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—HMOX1—breast cancer	8.73e-06	5.29e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTA2—breast cancer	8.67e-06	5.26e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GPX2—breast cancer	8.67e-06	5.26e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GPX4—breast cancer	8.57e-06	5.2e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SULT1A1—breast cancer	8.57e-06	5.2e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—KRAS—breast cancer	8.51e-06	5.16e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ABCB1—breast cancer	8.38e-06	5.08e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—IDH1—breast cancer	8.37e-06	5.08e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTA1—breast cancer	8.37e-06	5.08e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CA9—breast cancer	8.3e-06	5.03e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTA4—breast cancer	8.3e-06	5.03e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NAT2—breast cancer	8.27e-06	5.02e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GPX2—breast cancer	8.08e-06	4.9e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTA2—breast cancer	8.08e-06	4.9e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GPX4—breast cancer	7.99e-06	4.84e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SULT1A1—breast cancer	7.99e-06	4.84e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CA—breast cancer	7.82e-06	4.74e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTA1—breast cancer	7.8e-06	4.73e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—IDH1—breast cancer	7.8e-06	4.73e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NAT2—breast cancer	7.71e-06	4.68e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—DPYD—breast cancer	7.26e-06	4.4e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MED12—breast cancer	7.26e-06	4.4e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HRAS—breast cancer	7.23e-06	4.39e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALDOA—breast cancer	7.14e-06	4.33e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NCOA3—breast cancer	6.93e-06	4.21e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IL6—breast cancer	6.92e-06	4.2e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC2A2—breast cancer	6.89e-06	4.18e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—HRAS—breast cancer	6.8e-06	4.12e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MED12—breast cancer	6.76e-06	4.1e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—DPYD—breast cancer	6.76e-06	4.1e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MTR—breast cancer	6.75e-06	4.09e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ABCG2—breast cancer	6.75e-06	4.09e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CPT1A—breast cancer	6.75e-06	4.09e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALDOA—breast cancer	6.66e-06	4.04e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HPGDS—breast cancer	6.62e-06	4.01e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HBA1—breast cancer	6.57e-06	3.99e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CA—breast cancer	6.55e-06	3.97e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NCOA3—breast cancer	6.46e-06	3.92e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC2A2—breast cancer	6.42e-06	3.89e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTT1—breast cancer	6.42e-06	3.89e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ACHE—breast cancer	6.42e-06	3.89e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—AKT1—breast cancer	6.39e-06	3.88e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—HRAS—breast cancer	6.34e-06	3.84e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CPT1A—breast cancer	6.29e-06	3.81e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MTR—breast cancer	6.29e-06	3.81e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ABCG2—breast cancer	6.29e-06	3.81e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HPGDS—breast cancer	6.17e-06	3.74e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HBA1—breast cancer	6.13e-06	3.72e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP17A1—breast cancer	6.07e-06	3.68e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ENO1—breast cancer	6.01e-06	3.65e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTGS1—breast cancer	6.01e-06	3.65e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTT1—breast cancer	5.98e-06	3.63e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ACHE—breast cancer	5.98e-06	3.63e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP2D6—breast cancer	5.9e-06	3.58e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NCOA2—breast cancer	5.79e-06	3.51e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP17A1—breast cancer	5.66e-06	3.43e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ALB—breast cancer	5.62e-06	3.41e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—FASN—breast cancer	5.61e-06	3.4e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTGS1—breast cancer	5.6e-06	3.4e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ENO1—breast cancer	5.6e-06	3.4e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—BCHE—breast cancer	5.59e-06	3.39e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC5A5—breast cancer	5.52e-06	3.35e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP2D6—breast cancer	5.5e-06	3.33e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NCOA2—breast cancer	5.39e-06	3.27e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AKT1—breast cancer	5.35e-06	3.25e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NQO1—breast cancer	5.33e-06	3.23e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC2A1—breast cancer	5.33e-06	3.23e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ALB—breast cancer	5.24e-06	3.18e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—FASN—breast cancer	5.23e-06	3.17e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—BCHE—breast cancer	5.21e-06	3.16e-05	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—HRAS—breast cancer	5.21e-06	3.16e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP3A4—breast cancer	5.2e-06	3.15e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC5A5—breast cancer	5.15e-06	3.12e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP1B1—breast cancer	5.11e-06	3.1e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—RAF1—breast cancer	5.08e-06	3.08e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HSP90AA1—breast cancer	5.01e-06	3.04e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NQO1—breast cancer	4.97e-06	3.01e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC2A1—breast cancer	4.97e-06	3.01e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NCOA1—breast cancer	4.88e-06	2.96e-05	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—HRAS—breast cancer	4.85e-06	2.94e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP3A4—breast cancer	4.85e-06	2.94e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—STK11—breast cancer	4.81e-06	2.92e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP19A1—breast cancer	4.81e-06	2.92e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP1B1—breast cancer	4.76e-06	2.89e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—RAF1—breast cancer	4.74e-06	2.88e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HSP90AA1—breast cancer	4.67e-06	2.83e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NCOA1—breast cancer	4.55e-06	2.76e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP19A1—breast cancer	4.48e-06	2.72e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—STK11—breast cancer	4.48e-06	2.72e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—COMT—breast cancer	4.47e-06	2.71e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTP1—breast cancer	4.45e-06	2.7e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HMOX1—breast cancer	4.39e-06	2.66e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ITPR1—breast cancer	4.38e-06	2.65e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ABCB1—breast cancer	4.21e-06	2.55e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—COMT—breast cancer	4.16e-06	2.53e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTP1—breast cancer	4.15e-06	2.51e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TYMS—breast cancer	4.13e-06	2.51e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HMOX1—breast cancer	4.09e-06	2.48e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PLA2G4A—breast cancer	4.09e-06	2.48e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NCOR1—breast cancer	4.09e-06	2.48e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTM1—breast cancer	4.09e-06	2.48e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ITPR1—breast cancer	4.08e-06	2.47e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ABCB1—breast cancer	3.92e-06	2.38e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GPX1—breast cancer	3.91e-06	2.37e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP1A1—breast cancer	3.87e-06	2.35e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TYMS—breast cancer	3.85e-06	2.34e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ERCC2—breast cancer	3.84e-06	2.33e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PLA2G4A—breast cancer	3.81e-06	2.31e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NCOR1—breast cancer	3.81e-06	2.31e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTM1—breast cancer	3.81e-06	2.31e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GPX1—breast cancer	3.65e-06	2.21e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MTHFR—breast cancer	3.61e-06	2.19e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP1A1—breast cancer	3.61e-06	2.19e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ERCC2—breast cancer	3.58e-06	2.17e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MTHFR—breast cancer	3.37e-06	2.04e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CAV1—breast cancer	3.33e-06	2.02e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CAV1—breast cancer	3.11e-06	1.88e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CG—breast cancer	3.03e-06	1.84e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CG—breast cancer	2.83e-06	1.72e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CD—breast cancer	2.67e-06	1.62e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALB—breast cancer	2.63e-06	1.6e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NOS3—breast cancer	2.52e-06	1.53e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CD—breast cancer	2.49e-06	1.51e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALB—breast cancer	2.45e-06	1.49e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NOS3—breast cancer	2.35e-06	1.42e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CB—breast cancer	2.33e-06	1.41e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTGS2—breast cancer	2.3e-06	1.4e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CB—breast cancer	2.17e-06	1.31e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTGS2—breast cancer	2.15e-06	1.3e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTEN—breast cancer	2.01e-06	1.22e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTEN—breast cancer	1.87e-06	1.14e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CA—breast cancer	1.42e-06	8.6e-06	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CA—breast cancer	1.32e-06	8.01e-06	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AKT1—breast cancer	1.16e-06	7.02e-06	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AKT1—breast cancer	1.08e-06	6.55e-06	CbGpPWpGaD
